Allergic rhinitis
Conditions
Interventions
Autologous blood acupoint injection group:Autologous blood injection at acupoints
Fake acupoint and fake injection treatment group:False acupoint and false injection treatment
Acupoint injection of normal saline group:Inject normal saline at acupoints
Sponsors
Chengdu University of Traditional Chinese Medicine Affiliated Hospital Jinniu District Chengdu City Sichuan Province
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) Meet the above diagnostic criteria 2) Age: 18 to 70 years old (inclusive) gender not limited; 3) Those who have the ability to understand the nature of the research agree to participate in this trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Those with concurrent otorhinolaryngological infections or organic lesions such as sinusitis otitis media nasal polyps and deviated nasal septum; 2) Under 18 years old or over 70 years old; 3) Pregnant or lactating women; 4) Those with severe primary diseases such as cardiovascular liver kidney and hematopoietic system diseases mental patients and serious diseases that affect their quality of life; 5) Those who have used antihistamines or corticosteroids within the past month or received traditional Chinese acupuncture treatment or other related treatments that affect the judgment of therapeutic effects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rhinoconjunctivitis Quality of Life Questionnaire;Total Nasal Symptom Score;Physical sign score;Total Non-nasal Symptom Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum IL-10;NLRP3 in nasal mucosa tissue;Serum IL-1ß;Serum IgE;caspase-1 in nasal mucosa tissue;GSDMD in nasal mucosa tissue; | — |
Countries
China
Contacts
Public ContactPengShunlin
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Outcome results
None listed